t
Fevertree Drinks plc purchased a total of 153,634 of its own ordinary shares of £0.0025 each, via Investec Bank plc, between August 17th and August 21st, 2026. This action was taken under the authority granted by shareholders at its 2025 Annual General Meeting on June 5th, and the company intends to cancel the purchased shares, which were acquired at prices ranging from 832.5000p to 866.5000p.
| Date | 25 Aug 2026 |
| Time | 07:00:01 |
| Category | Capital structure |
| ID | 8575R |
25th August 2026
Fevertree Drinks plc
("Fever-Tree" or the "Company")
Transaction in Own Shares
Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 17th August to 21st August 2026.
|
Date |
Venue |
Volume-weighted average price (p) |
Aggregated volume |
Lowest price per share (p) |
Highest price per share (p) |
|
17 August 2026 |
XLON |
853.5254 |
28,423 |
839.5000 |
866.5000 |
|
17 August 2026 |
AIMX |
845.2000 |
20,000 |
845.2000 |
845.2000 |
|
18 August 2026 |
XLON |
846.0929 |
16,353 |
838.0000 |
852.5000 |
|
19 August 2026 |
XLON |
839.4961 |
37,444 |
832.5000 |
842.0000 |
|
19 August 2026 |
AIMX |
835.5000 |
15,936 |
835.5000 |
835.5000 |
|
20 August 2026 |
XLON |
842.6699 |
27,112 |
832.5000 |
849.5000 |
|
21 August 2026 |
XLON |
849.8050 |
8,366 |
845.5000 |
854.0000 |
The Company intends to cancel the purchased shares.
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.
http://www.rns-pdf.londonstockexchange.com/rns/8575R_1-2026-8-24.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
For further information please contact:
Investor queries
Steve Nightingale, Director of Investor Relations I [email protected] I +44 (0)7951 849564
Media queries
Oliver Winters, Director of Communications I [email protected] I +44 (0)770 332 9024